Actively Recruiting
Efficacy and Safety of Photodynamic Therapy for Cervical and Vaginal Intraepithelial Neoplasia
Led by Peking University Third Hospital · Updated on 2025-05-21
250
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical and vaginal intraepithelial neoplasia in women in the real world.
CONDITIONS
Official Title
Efficacy and Safety of Photodynamic Therapy for Cervical and Vaginal Intraepithelial Neoplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women with cervical or vaginal high-grade squamous intraepithelial lesions (HSILs) confirmed by colposcopy and biopsy (CIN2/CIN3 and/or VaIN2/VaIN3) or persistent CIN1/VaIN1 lasting more than one year with strong willingness to receive treatment
- Adequate colposcopy with analysable colposcopy images available
- Endocervical curettage (ECC) showing no higher-grade lesions
You will not qualify if you...
- Presence or suspicion of cancer
- Porphyria or known allergies to red or blue light
- Severe medical comorbidities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Unniversity Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
Q
Qin Han
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here